Emerging Technologies in Drug Discovery and Development

IMIHGOM and Mimetas are jointly organising a symposium focused on ‘Emerging Technologies in Drug Discovery and Development’. The symposium will take place on Thursday, August 23rd on the Leiden BioScience Park.

A panel of interesting speakers have been lined up, including Marco de Boer (NTrans Technologies); Tomas Bos (Glycostem); and Frank Beurskens (Genmab). Each speaker will address the scientific implications of their company’s technology in drug discovery and development programmes. In addition, two students will present their business development internships.

Attendance is free, kindly register by sending an email to osmulders@imihgom.com. The closing day for registration is Tuesday August 21st. Walk-ins are welcome.

Programme Details:

Thursday, August 23, 2018
14:30
Biopartner Building 1 (Auditorium)
J.H. Oortweg 21, 2333 CH, Leiden

  • 14:30 Walk-in
  • 15:00 NTrans Technologies – Marco de Boer (CEO)
     ‘iTOP: CRISPR delivery with a pinch of salt’
  • 15:40 IMIHGOM B.V. – Olivier Smulders (Intern)
    ‘Technology landscape in oncology drug discovery and drug development’
  • 16:00 Mimetas – Karin de Nijs (Intern)
  • 16:20 Break
  • 16:40 Glycostem – Tomas Bos (Senior Research Manager)
    ‘CAR-NK: the big promise for a universal cancer cure’
  • 17:20 Genmab – Frank Beurskens (Senior Scientist)
    ‘Translating antibody structure-function relations into therapy: the power of imagination’
  • 18:00 Drinks

 

PDF Symposium Flyer

IMIHGOM at Business Development Program summer conference

IMIHGOM CEO Mona Moghimi will speak at the Business Development Program summer conference hosted by Ernst & Young in Amsterdam, The Netherlands on 25th and 26th September 2018. The BDP Course specifically aims at junior to mid-level BD professionals who are driven to expand their knowledge on the BD process and to strengthen their BD competences.

Mona will join a panel of experts in sharing their experiences and insights in successful business development. Topics covered will includepartner search, valuation, negotiation, legal aspects, deal structures and finance.

 

IMIHGOM Attends SWISS HLG & PLCF Summer Conference, Basel

IMIHGOM recently attended the SWISS HLG & PLCF Summer conference at Novartis in Basel, Switzerland. The topic of this meeting was ‘Innovation in Healthcare: From Technology to Business Models and Transactions’, and was jointly organised by the Swiss Healthcare Licensing Group (HLG) and the Pharma Licensing Club France (PLCF).

 

Mona Moghimi joined 130 other participants to hear key success stories of innovative companies in Switzerland and France. In addition, key challenges were addressed, ranging from innovation, financing, and deal-making processes across immuno-oncology, digital health, and big data.

IMIHGOM attends Innovation for Health, Rotterdam

IMIHGOM recently attended the Innovation for Health event in Rotterdam. Now in its fifth year, Innovation for Health is the premier event for key players in Health and Life Sciences in The Netherlands.

Mona Moghimi and Thomas Costelloe joined other stakeholders in Health and Life Sciences to hear about latest developments, establish new contacts and catch up with old friends. Together, we aim to Shape the Future of healthcare!

IMIHGOM attends the Dutch Life Sciences Conference, Oss

IMIHGOM recently attended the Dutch Life Sciences Conference (DLSC) at the Pivot Park in Oss. The DLSC is the foremost life sciences business network event in The Netherlands.

Mona Moghimi joined over 450 life sciences companies in the Dutch Life Sciences sector in the 13th edition of the DLSC to hear about the latest developments, establish new contacts and catch up with old friends. Together, we aim to Shape the Future of healthcare!

IMIHGOM attends the Pivot Oncology Conference, Oss

IMIHGOM recently attended the Pivot Oncology Conference in Oss. During this 5th year anniversary Pivot Oncology Conference, the audience learned from (inter)national renowned pioneers in the field of immuno-oncology of breakthroughs in precision medicine used for cancer treatment from both the scientific and business perspective.

IMIHGOM attends Bio-Europe, Berlin

IMIHGOM recently attended Bio-Europe in Berlin, Germany. Bio-Europe is Europe’s largest partnering conference serving the global biotechnology industry. Bio-Europe’s world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivalled forum for companies across the biotech value chain to meet and do business.

IMIHGOM representatives took part in over 40 one-to-one meetings with key decision makers in the biopharmaceutical market. The one-to-one meetings were a combination of meetings where IMIGHOM representatives introduced their client’s services (Technology), discussed licensing opportunities (Venture) and show-cased its services to new clients.

IMIHGOM attends the Start-up Fest Europe, Amsterdam

IMIHGOM attended the Start-up Fest Europe in Amsterdam, The Netherlands. Startup Fest Europe is the one stop shop for start-ups and scale-ups that want to do business by changing the world. The 2017 edition was initiated by StartupDelta and organised in close collaboration with the Dutch start-up ecosystem and major international corporates.

IMIHGOM representatives took part in over 15 one-to-one meetings in one day, showcasing its services to key players in the European biopharmaceutical market.

IMIHGOM attends Innovation for Health, Rotterdam

IMIHGOM recently attended the Innovation for Health event in Rotterdam. Now in its fourth year, Innovation for Health is the premier event for key players in Health and Life Sciences in The Netherlands.

Mona Moghimi joined other stakeholders in Health and Life Sciences to hear about latest developments, establish new contacts and catch up with old friends. Together, aim to Shape the Future of healthcare!